|Other Names||Nexavar, 284461-73-0, sorafenibum, BAY 43-9006, Sorafenib [INN], Kinome_766, UNII-9ZOQ3TZI87, AC1L50CF, BAY-43-9006|
|Pharmaceutical Company||Bayer and Onyx Pharmaceuticals|
|Treatment By||Pill - Oral|
|Tumor Target||Intracranial Schwannoma|
|NF2 Trials||Recruiting Trial: CPMS10563|
|Inhibitor||several Tyrosine protein kinases (VEGFR and PDGFR) and Raf kinases (more avidly C-Raf than B-Raf), simultaneous targeting of the Raf/Mek/Erk pathway|
Major side effects are uncommon. Since people with NF2 are taking these medications at a low dose, only minimal side effects are common. However, long term use is primarily where these major side effects take place. Monthly Blood and Urine Tests can usually point to an issue before it's a real problem. Talk to your doctor.